Featuring the world's longest projected longevity.1–4

Platinium™ 4LV CRT-D is small in design with no compromise on longevity.
PLATINIUM-4LV-CRT-D-1744_MicroPort_front

Featuring

Parad+™

World's first dual-chamber discrimination algorithm.

Featuring

BTO™

Brady-Tachy OverlapTM is the world’s only CRT-D technology allowing pacing therapy during exercise.
 

More LV vectors for flexible pacing

  • Multiple choice among 14 LV vectors
  • Reduced risk of phrenic nerve stimulation5
  • Lower pacing threshold5

Dedicated LV test assistant for quick LV pacing selection

  • Automatic sequential testing
  • Results on all vectors at a glance
  • Previous test data included

World's longest longevity1–4

10.9-year longevity.

Longevity is based on real life pacing conditions.6

Backed by warranty.7

Extended 7-year warranty.

Warranty applies regardless of the pacing conditions and therapy frequency.7

Breakthrough technology that stands the test of time.

  • 40% reduced electronic consumption8
  • 20% improved battery capacity8
  • Reforming-free capacitors mean zero energy is wasted

Protect your patients from replacements.

The time has come to close the gap between patient life expectancy and device longevity.

84% of patients would not need a replacement if their device were to last more than 9 years.9

 

Visit the Cardiac Device Longevity website for more information.

 

Small size

PlatiniumTM is designed to facilitate the implant experience and improve patient comfort.

  • Rounded edges
  • Reduced pocket size
  • Allows for smaller incision
  • Better fit for replacements

 

Ergoform™ design

PlatiniumTM with its smooth and curved header is designed for natural lead wrap around.

 

Parad+™

Protecting patients for over 20 years.

  • World’s first dual-chamber discrimination algorithm
  • Best in class 99% specificity10
  • Low inappropriate shock rate11
  • Immediate protection with PARAD+TM out-of-the-box setting*

 

 

 

BTO™

Active resynchronization.

The world’s only CRT-D device allowing Brady-Tachy OverlapTM.

BTOTM:

  • Ensures resynchronization whatever the patients’ condition
  • Detects and treats VT with painless therapy
  • Delivers CRT pacing during exercise for cardiac rehabilitation
  • 96% specificity in slow VT zone12
  • A proof of PARAD+TM discrimination performance
 

*Not applicable to USA devices.

This product may not be for sale in your country or your area. For further information on product availability, please contact your local representative.

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For indications, contraindications, precautions and warnings for each device, please refer to the product manual.

References

  1. Medtronic. CLARIA MRI™ QUAD CRT-D SureScan™ DTMA2QQ Device manual M956980A001 B 2017-07-17. 
  2. (EU) Biotronik. ILIVIA™ 7 VR-T, VR-T DX, DR-T, HF-T, HF-T QP (ProMRI®) Technical Manual 417641 Revision: D (2016-08-09).
    (US) Biotronik. ILIVIA ProMRI™ Family of ICDs and CRT-Ds. Technical Manual M4206-B 01/18/MN070 1/23/18.
  3. (EU) Saint Jude Medical – Bradycardia and Tachycardia Devices – Help Manual – June 2013 Art 60033180/A.
    (US) Saint Jude Medical. Bradycardia and Tachycardia Devices Help Manual. 2017 ARTEN100161329 A.
  4. (EU) Physician’s technical manual RESONATE™ HF CRT-D, RESONATE™ CRT-D, RESONATE™ X4 CRT-D, CHARISMA™ CRT-D, CHARISMA™ X4 CRT-D, VIGILANT™ CRT-D, VIGILANT™ X4 CRT-D, MOMENTUM™ CRT-D, MOMENTUM™ CRT-D X4 – Cardiac Resynchronization Therapy Defibrillator 360203-001 EN Europe 2016-09.
    (US) Boston Scientific. Physician’s technical manual AUTOGEN™ CRT-D, AUTOGEN™ X4 CRT-D, DYNAGEN™ CRT-D, DYNAGEN™ X4 CRT-D, INOGEN™ CRT-D, INOGEN™ X4 CRT-D, ORIGEN™ CRT-D, ORIGEN™ X4 CRT-D, INCEPTA™ CRT-D, ENERGEN™ CRT-D, PUNCTUA™ CRT-D, COGNIS™ 100-D CRT-D – Cardiac Resynchronization Therapy Defibrillator – 359401-004 EN US 2017-04.
  5. Oswald H, et al. Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients with Quadripolar LV Leads: The EffaceQ Study. Pacing Clin Electrophysiol. 2015;38:942–50.
  6. Functioning conditions for projected longevity (conditions based on MicroPort CRM data on file): CRT-D models: Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60min-1, 600Ω, A & RV pacing amplitude 2.5V, LV pacing amplitude 3V, 0.35ms, 3 max shocks per year, sensor OFF. Longevity is calculated by taking into account 6 months storage with the following conditions: Remote ON: daily check, 4 follow-ups and 5 full alert reports per year. RF telemetry ON: 120min at implant + 15min at discharge + 15min in-clinic quarterly FU.
  7. (EU) Product manual. U666 – LIMITED WARRANTY for PLATINIUM ICD & CRT-D devices.
    (US)  Product manual. U668 – LIMITED WARRANTY for PLATINIUM ICD & CRT-D devices.
  8. Versus previous CRT-D generation (Paradym RF). Manual available at www.microportmanuals.com
  9. Ramachandra I. Impact of ICD battery Longevity on Need for Device Replacements-Insight from Veterans Affairs Database. PACE. 2010;33:314–19.
  10. Hintringer F, et al. Comparison of the Specificity of Implantable Dual Chamber Defibrillator Detection Algorithms. Pacing Clin Electrophysiol 2004;27:976–82.
  11. Kolb C, et al. Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy. Results of the randomized Option study. JACC Heart Fail. 2014;2:611–19.
  12. Sadoul N, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation. 2005;112:946–53.
Exemplary message

By continuing to browse this website you confirm that you are a healthcare professional.